Stockreport

Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPa Monoclonal Antibody for Advanced Solid Tumors [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF NEWARK, Del. and NANJING, China Feb. 3, 2026 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-ba [Read more]